423 related articles for article (PubMed ID: 23298961)
1. Metabolic endotoxaemia: is it more than just a gut feeling?
Piya MK; Harte AL; McTernan PG
Curr Opin Lipidol; 2013 Feb; 24(1):78-85. PubMed ID: 23298961
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
Frazier TH; DiBaise JK; McClain CJ
JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
[TBL] [Abstract][Full Text] [Related]
3. The gut microbiota, obesity and insulin resistance.
Shen J; Obin MS; Zhao L
Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
[TBL] [Abstract][Full Text] [Related]
4. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism.
Caesar R; Fåk F; Bäckhed F
J Intern Med; 2010 Oct; 268(4):320-8. PubMed ID: 21050286
[TBL] [Abstract][Full Text] [Related]
5. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes.
Musso G; Gambino R; Cassader M
Annu Rev Med; 2011; 62():361-80. PubMed ID: 21226616
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
[TBL] [Abstract][Full Text] [Related]
7. Flos Lonicera ameliorates obesity and associated endotoxemia in rats through modulation of gut permeability and intestinal microbiota.
Wang JH; Bose S; Kim GC; Hong SU; Kim JH; Kim JE; Kim H
PLoS One; 2014; 9(1):e86117. PubMed ID: 24475077
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.
Bleau C; Karelis AD; St-Pierre DH; Lamontagne L
Diabetes Metab Res Rev; 2015 Sep; 31(6):545-61. PubMed ID: 25352002
[TBL] [Abstract][Full Text] [Related]
9. Role of the gut in visceral fat inflammation and metabolic disorders.
Lam YY; Mitchell AJ; Holmes AJ; Denyer GS; Gummesson A; Caterson ID; Hunt NH; Storlien LH
Obesity (Silver Spring); 2011 Nov; 19(11):2113-20. PubMed ID: 21881620
[No Abstract] [Full Text] [Related]
10. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
Esteve E; Ricart W; Fernández-Real JM
Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
[TBL] [Abstract][Full Text] [Related]
11. Obesity, metabolic syndrome, and microbiota: multiple interactions.
Tilg H
J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S16-8. PubMed ID: 20535027
[TBL] [Abstract][Full Text] [Related]
12. Influence of diet on gut microbiota, inflammation and type 2 diabetes mellitus. First experience with macrobiotic Ma-Pi 2 diet.
Fallucca F; Porrata C; Fallucca S; Pianesi M
Diabetes Metab Res Rev; 2014 Mar; 30 Suppl 1():48-54. PubMed ID: 24532292
[TBL] [Abstract][Full Text] [Related]
13. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.
Murphy EF; Cotter PD; Hogan A; O'Sullivan O; Joyce A; Fouhy F; Clarke SF; Marques TM; O'Toole PW; Stanton C; Quigley EM; Daly C; Ross PR; O'Doherty RM; Shanahan F
Gut; 2013 Feb; 62(2):220-6. PubMed ID: 22345653
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
[TBL] [Abstract][Full Text] [Related]
15. Managing the manager: gut microbes, stem cells and metabolism.
Serino M; Blasco-Baque V; Nicolas S; Burcelin R
Diabetes Metab; 2014 Jun; 40(3):186-90. PubMed ID: 24462190
[TBL] [Abstract][Full Text] [Related]
16. [Research advances in the gut microbiota and inflammation in obesity].
Cao ZJ; Yu JC; Kang WM; Ma ZQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):462-5. PubMed ID: 23987498
[TBL] [Abstract][Full Text] [Related]
17. Intestinal microbiota and obesity.
Blaut M; Klaus S
Handb Exp Pharmacol; 2012; (209):251-73. PubMed ID: 22249818
[TBL] [Abstract][Full Text] [Related]
18. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
Diamant M; Blaak EE; de Vos WM
Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
[TBL] [Abstract][Full Text] [Related]
19. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice.
Neyrinck AM; Possemiers S; Verstraete W; De Backer F; Cani PD; Delzenne NM
J Nutr Biochem; 2012 Jan; 23(1):51-9. PubMed ID: 21411304
[TBL] [Abstract][Full Text] [Related]
20. The influence of endotoxemia on the molecular mechanisms of insulin resistance.
Boroni Moreira AP; de Cássia Gonçalves Alfenas R
Nutr Hosp; 2012; 27(2):382-90. PubMed ID: 22732959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
